- Joined
- Jul 10, 2012
- Messages
- 39
- Reaction score
- 45
Anecdotally some dermatologists I've talked to would set up a separate "procedure only day." Many PCPs in my area who perform biopsies already schedule separate "procedure visits" for biopsies. This has the following ethical considerations:
1. Patients may need to take extra time off work (2 days instead of 1 day).
2. While most would (probably correctly) argue that delaying a biopsy by <5 days would have negligible risk on progression of a suspected skin cancer, would this result in an increased malpractice risk (invasive melanoma, MCC, etc)?
3. Patient waiting times would increase, as a patient needing a biopsy would effectively take up 1.5-2 patient slots instead of 1.
4. Reimbursement would still decrease overall, as you would be using ~two appointment slots to get the same effective reimbursement as an RV3 + mod 25 for biopsy. Sure, the procedure visit would be quick, but you still have to repeat intake + room turnover.
5. If a separate procedure day were being considered, would the rates of excisional biopsies (e.g. for clinically dysplastic nevi) increase? Would this affect SLNB accuracy if the result came back as melanoma?
6. Probably cryotherapy and Efudex would be a thing of the past for AKs, and everyone would start doing PDT and setting up separate PDT days.
Others say it would be the final straw, and if reimbusement is cut too much they might as well transition to a direct pay/cash only model, outside of the medical insurance reimbursement structure entirely. While their overall revenue would be reduced, it would also come with less overhead and less headaches (theoretically).
If modifier 25 were cut or nerfed, how would you deal with it?
1. Patients may need to take extra time off work (2 days instead of 1 day).
2. While most would (probably correctly) argue that delaying a biopsy by <5 days would have negligible risk on progression of a suspected skin cancer, would this result in an increased malpractice risk (invasive melanoma, MCC, etc)?
3. Patient waiting times would increase, as a patient needing a biopsy would effectively take up 1.5-2 patient slots instead of 1.
4. Reimbursement would still decrease overall, as you would be using ~two appointment slots to get the same effective reimbursement as an RV3 + mod 25 for biopsy. Sure, the procedure visit would be quick, but you still have to repeat intake + room turnover.
5. If a separate procedure day were being considered, would the rates of excisional biopsies (e.g. for clinically dysplastic nevi) increase? Would this affect SLNB accuracy if the result came back as melanoma?
6. Probably cryotherapy and Efudex would be a thing of the past for AKs, and everyone would start doing PDT and setting up separate PDT days.
Others say it would be the final straw, and if reimbusement is cut too much they might as well transition to a direct pay/cash only model, outside of the medical insurance reimbursement structure entirely. While their overall revenue would be reduced, it would also come with less overhead and less headaches (theoretically).
If modifier 25 were cut or nerfed, how would you deal with it?